Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Share-based Compensation (2021 - 2026)

Alvotech's (ALVO) quarterly Share-based Compensation came in at $2.9 million in Q2 2026, up 38.44% on a YoY basis from $2.1 million in Q2 2025, and up 24.62% quarter-over-quarter from $2.3 million in Q1 2026.

Analysis

Alvotech (ALVO) Share-based Compensation (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Share-based Compensation for 6 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation rose 38.44% year-over-year to $2.9 million; the trailing twelve-month figure through Jun 2026 stood at $9.2 million (up 60.43% YoY), and the FY2025 full-year result was $7.4 million, down 3.25% from the prior year.
  • Share-based Compensation climbed to $2.9 million in Q2 2026 per ALVO's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $20.6 million in Q4 2022 and bottomed at -$503000.0 in Q4 2025.
  • Historically, Share-based Compensation has averaged $3.9 million across 5 years, with a median of $2.7 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Share-based Compensation jumped 221.64% in 2022, then tumbled 109.0% in 2024.
  • Over 5 years, Share-based Compensation stood at $20.6 million in 2022, then slumped by 86.25% to $2.8 million in 2023, then plunged by 109.0% to -$255000.0 in 2024, then tumbled by 97.25% to -$503000.0 in 2025, then surged by 680.72% to $2.9 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $2.9 million, $2.3 million, and -$503000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 40.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 30.40 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 1.02 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 176,000.00
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 54.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 2.92 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 11.41 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 29.30 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 7.04 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.92 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 -503,000.00
Sep 30, 2025 4.46 Mn
Jun 30, 2025 2.11 Mn
Mar 31, 2025 1.31 Mn
Dec 31, 2024 -255,000.00
Sep 30, 2024 2.59 Mn
Jun 30, 2024 2.47 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 2.83 Mn
Jun 30, 2023 6.67 Mn
Dec 31, 2022 20.61 Mn
Jun 30, 2022 3.73 Mn
Dec 31, 2021 6.41 Mn
Sep 30, 2021 -905,000.00